LXF-75036-86083
1 vaccination
1 coded response
12 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 662 / KS
- Registered
- 2022-06-29
- Relationship
- Child or adolescent in my care
- Guardian
- 2B5-86896-30065
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-29
Registered in v-safe
-
2022-06-29
Dose 1 — Pfizer-BioNTech
-
2022-06-29
Health check-in — day 0, dose 1, under 3Feeling: Good · Site: Redness · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-06-30
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-07-01
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-07-02
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
- 2022-07-03
- 2022-07-04
- 2022-07-05
- 2022-07-06
- 2022-07-13
-
2022-07-20
Survey response — day 21, dose 1, under 3MedDRA: Bronchitis, Respiratory syncytial virus infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: RSV/bronchitisMedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Report sent to call center — day 21, dose 1, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-07-21
-
2022-07-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-12-28
- 2023-06-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-29 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-20 | Successful 2022-07-21 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: RSV/bronchitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release